Alvarez-Lerma F - Search Results

1

Risk factors for candidaemia in critically ill patients: a prospective surveillance study.

Jordà-Marcos R, Alvarez-Lerma F, Jurado M, Palomar M, Nolla-Salas J, León MA, León C; EPCAN Study Group. Jordà-Marcos R, et al. Mycoses. 2007 Jul;50(4):302-10. doi: 10.1111/j.1439-0507.2007.01366.x. Mycoses. 2007. PMID: 17576324

2

Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC).

Vallés J, León C, Alvarez-Lerma F. Vallés J, et al. Clin Infect Dis. 1997 Mar;24(3):387-95. doi: 10.1093/clinids/24.3.387. Clin Infect Dis. 1997. PMID: 9114190

3

[Indications for admission to the intensive care service of adult patients with severe infections].

Alvarez Lerma F, Cisneros JM, Fernández-Viladrich P, León C, Miró JM, Pachón J, Palomar M, Rello J. Alvarez Lerma F, et al. Enferm Infecc Microbiol Clin. 1998 Nov;16(9):423-30. Enferm Infecc Microbiol Clin. 1998. PMID: 9887630 Review. Spanish. No abstract available.

4

Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial.

Alvarez-Lerma F, Insausti-Ordeñana J, Jordá-Marcos R, Maraví-Poma E, Torres-Martí A, Nava J, Martínez-Pellús A, Palomar M, Barcenilla F; Spanish Collaborative Group for the Study of Severe Infections. Alvarez-Lerma F, et al. Intensive Care Med. 2001 Mar;27(3):493-502. doi: 10.1007/s001340000846. Intensive Care Med. 2001. PMID: 11355117 Clinical Trial.

5

Management of antimicrobial use in the intensive care unit.

Alvarez-Lerma F, Palomar M, Grau S. Alvarez-Lerma F, et al. Drugs. 2001;61(6):763-75. doi: 10.2165/00003495-200161060-00005. Drugs. 2001. PMID: 11398908 Review.

6

[Cefotaxime, twenty years later. Observational study in critically ill patients].

Alvarez-Lerma F, Palomar M, Olaechea P, Sierra R, Cerda E; Grupo de Estudio de Infección en el Paciente Crítico. Alvarez-Lerma F, et al. Enferm Infecc Microbiol Clin. 2001 May;19(5):211-8. doi: 10.1016/s0213-005x(01)72615-8. Enferm Infecc Microbiol Clin. 2001. PMID: 11446909 Spanish.

7

[Risk and prognostic factors of Pseudomonas aeruginosa bacteremia in critically ill patients].

Alvarez-Lerma F, Pavesi M, Calizay M, Valles J, Palomar M; Grupo de Estudio de Bacteriemias en Pacientes Criticos de la SEMICYUC. Alvarez-Lerma F, et al. Med Clin (Barc). 2001 Dec 8;117(19):721-6. doi: 10.1016/s0025-7753(01)72237-3. Med Clin (Barc). 2001. PMID: 11737996 Spanish.

8

[Treatment approach for fungal infections in critically ill patients admitted to intensive care units: results of a multicenter survey].

Alvarez-Lerma F, Nolla J, Palomar M, León MA. Alvarez-Lerma F, et al. Enferm Infecc Microbiol Clin. 2003 Feb;21(2):83-8. doi: 10.1016/s0213-005x(03)72888-2. Enferm Infecc Microbiol Clin. 2003. PMID: 12586031 Spanish.

9

Olaechea PM, Ulibarrena MA, Alvarez-Lerma F, Insausti J, Palomar M, De la Cal MA; ENVIN-UCI Study Group. Olaechea PM, et al. Infect Control Hosp Epidemiol. 2003 Mar;24(3):207-13. doi: 10.1086/502191. Infect Control Hosp Epidemiol. 2003. PMID: 12683514

10

Candiduria in critically ill patients admitted to intensive care medical units.

Alvarez-Lerma F, Nolla-Salas J, León C, Palomar M, Jordá R, Carrasco N, Bobillo F; EPCAN Study Group. Alvarez-Lerma F, et al. Intensive Care Med. 2003 Jul;29(7):1069-76. doi: 10.1007/s00134-003-1807-y. Epub 2003 May 16. Intensive Care Med. 2003. PMID: 12756441

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters